2322 - Effectiveness of Recombinant Influenza Vaccine vs. Standard Dose Inactivated Influenza Vaccines Against Hospitalized Influenza-Related Outcomes in Adults: A Cluster Randomized Trial

Co-Author(s)

• AH

  Amber Hsiao, MPH

  Senior Research Project Manager
  Division of Research Kaiser Permanente Vaccine Study Center
  Oakland, California, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• AY

  Arnold Yee, MA

  Senior Data Consultant
  Division of Research Kaiser Permanente Vaccine Study Center
  Oakland, California, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• BF

  Bruce Fireman, MA

  Research Scientist
  Division of Research Kaiser Permanente Vaccine Study Center
  Oakland, California, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• 

  John R. Hansen, MPH

  Group Leader Consulting
  Division of Research Kaiser Permanente Vaccine Study Center
  Oakland, California, United States

  Disclosure: Disclosure(s): No financial relationships to disclose
• NL

  Ned Lewis, MPH

  Data Manager/Group Leader
  Division of Research Kaiser Permanente Vaccine Study Center
  Oakland, California, United States

  Disclosure: Disclosure(s): No financial relationships to disclose

Presenting Author(s)

• 

  Nicola P. Klein, MD, PhD

  Director, Kaiser Permanente Vaccine Study Center and Senior Research Scientist
  Division of Research Kaiser Permanente Vaccine Study Center
  Oakland, CA, United States

  Disclosure: Disclosure(s): No financial relationships to disclose

  Slides